[HTML][HTML] The efficacy and safety of rebamipide ophthalmic suspension (opc-12759) in patients with dry eye disease: A systematic review of randomized controlled trials

A Ballesteros-Sánchez, MC Sánchez-González… - Journal of Clinical …, 2023 - mdpi.com
The aim of this paper is to evaluate the efficacy and safety of Rebamipide (REB) ophthalmic
suspension in dry eye disease (DED). A systematic review that only included full-length …

An Overview of Data Collection in Health Preference Research

S Ozdemir, M Quaife, AF Mohamed… - The Patient-Patient …, 2024 - Springer
This paper focuses on survey administration and data collection methods employed for
stated-preference studies in health applications. First, it describes different types of survey …

[HTML][HTML] Pharmacological in vitro profiling of Buddleja officinalis flower extracts in the context of dry eye disease

A Areesanan, A Wasilewicz, B Kirchweger… - Biomedicine & …, 2024 - Elsevier
Background Dry eye disease (DED) is caused by inflammation on the ocular surface and
insufficient quality or production of the tear film. Due to various harmful environmental …

A hyaluronic acid-modified cyclodextrin self-assembly system for the delivery of β-carotene in the treatment of dry eye disease

F Zhang, M Tan, ZE Hu, YT Zhang, XW Qi… - International Journal of …, 2025 - Elsevier
Dry eye disease (DED) is a multifactorial ocular disease, the core mechanism of which is the
tear film instability caused by ocular oxidative stress damage and inflammation. Although …

How Much Better is Faster? Empirical Tests of QALY Assumptions in Health-Outcome Sequences

FR Johnson, JJ Sheehan, S Ozdemir, M Wallace… - …, 2025 - Springer
Objectives This study was designed to test hypotheses regarding the path dependence of
health-outcome values in the form of linear additivity of health-state utilities and diminishing …

[PDF][PDF] Applications of Diquafosol Sodium in Ophthalmology: A Comprehensive Review on Therapeutic Utility

CQL Tan, D Wu, XY Toh, BX Lim, KC Shih, L Tong… - 2025 - preprints.org
Diquafosol is a purinergic P2Y2 receptor agonist that is garnering much interest for its
potential therapeutic benefits in dry eye disease (DED) management and is used commonly …

[PDF][PDF] Apteekin asiakkaiden näkemyksiä ja kokemuksia kuivasilmäisyyden hoitoon tarkoitetuista itsehoitovalmisteista

J Lipponen, K Sepponen, K Kajander, M Ruponen… - 2023 - dosis.fi
Dry eye disease is a common ailment that reduces the patients' quality of life and causes
costs such as medical expenses and sick leave. The treatment of dry eye disease is …

[SITAT][C] Current Management of Dry Eye due to The Influence of drugs

MV Jessica, L Laudita, KD Lina, S Anugrahsari - Jurnal MedScientiae, 2023